And what makes a new candidate drug called COYA 302, an investigational therapy for ALS, different? COYA 302 is a dual-mechanism investigational biologic combination therapy. To explore this ...
BEIJING/SHANGHAI (Reuters) -China plans to issue guidance to encourage the use of open-source RISC-V chips nationwide for the first time, two sources briefed on the matter said, as Beijing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback